Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Observational Study of the Expression of ABCB1 / P-glycoprotein as a Factor for the Biological Stratification of Non-metastatic Osteosarcoma of the Extremities

Next Previous
X
Search
Trial Profile

Prospective Observational Study of the Expression of ABCB1 / P-glycoprotein as a Factor for the Biological Stratification of Non-metastatic Osteosarcoma of the Extremities

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cisplatin (Primary) ; Doxorubicin (Primary) ; Ifosfamide (Primary) ; Methotrexate (Primary) ; Mifamurtide (Primary)
  • Indications Osteosarcoma
  • Focus Therapeutic Use

    • Most Recent Events

    • 03 Aug 2021 Status changed from recruiting to completed.
    • 26 Jul 2021 New trial record
    • 08 Jun 2021 Results (n=274) of a combined analysis from an Italian (ISG) and a Spanish (GEIS) sarcoma groups from two clinical studies: NCT01459484 and NCT04383288 presented at the 57th Annual Meeting of the American Society of Clinical Oncology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top